Truvestments Capital’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.9K | Hold |
318
| – | – | ﹤0.01% | 602 |
|
2025
Q1 | $8.7K | Sell |
318
-33
| -9% | -$903 | ﹤0.01% | 678 |
|
2024
Q4 | $14.1K | Buy |
351
+54
| +18% | +$2.17K | ﹤0.01% | 545 |
|
2024
Q3 | $14.1K | Buy |
+297
| New | +$14.1K | ﹤0.01% | 533 |
|
2024
Q2 | – | Sell |
-163
| Closed | -$6.55K | – | 473 |
|
2024
Q1 | $6.55K | Hold |
163
| – | – | ﹤0.01% | 530 |
|
2023
Q4 | $4.15K | Hold |
163
| – | – | ﹤0.01% | 615 |
|
2023
Q3 | $2.27K | Hold |
163
| – | – | ﹤0.01% | 580 |
|
2023
Q2 | $3.75K | Hold |
163
| – | – | ﹤0.01% | 553 |
|
2023
Q1 | $4.83K | Buy |
163
+104
| +176% | +$3.08K | ﹤0.01% | 515 |
|
2022
Q4 | $1.47K | Hold |
59
| – | – | ﹤0.01% | 780 |
|
2022
Q3 | $1K | Hold |
59
| – | – | ﹤0.01% | 591 |
|
2022
Q2 | $1K | Buy |
+59
| New | +$1K | ﹤0.01% | 605 |
|